Johnson & Johnson recently rolled out a TV ad that takes aim at a major disparity in dermatology: the fact that people of color with psoriasis are 70% less likely to be prescribed a biologic than ...
Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad spending rankings. Indeed, since September, they’d taken turns alternating between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results